Exact Sciences Corp (EXAS)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$62.50
Buy
$63.20
$1.58 (+2.57%)
Prices updated at 11 Dec 2024, 23:29 EST
| Prices minimum 15 mins delay
Prices in USD
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2023 | 73.83 |
| 2022 | 72.44 |
| 2021 | 74.04 |
| 2020 | 76.24 |
| 2019 | 75.27 |
| 2018 | 74.33 |
| 2017 | 70.56 |
| 2016 | 54.52 |
| 2015 | 37.88 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2024 | 4.19 |
| 2023 | 5.51 |
| 2022 | 4.32 |
| 2021 | 7.40 |
| 2020 | 14.75 |
| 2019 | 16.23 |
| 2018 | 19.21 |
| 2017 | 27.77 |
| 2016 | 16.86 |
| 2015 | 31.05 |
| 2014 | 1,583.01 |
Price/Forward earnings (YTD)
-312.50
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2023 | -3.22 |
| 2022 | -9.66 |
| 2021 | -10.26 |
| 2020 | -19.54 |
| 2019 | -8.47 |
| 2018 | -16.50 |
| 2017 | -23.45 |
| 2016 | -45.13 |
| 2015 | -46.63 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2023 | 2.06 |
| 2022 | 2.05 |
| 2021 | 1.97 |
| 2020 | 2.20 |
| 2019 | 1.53 |
| 2018 | 2.24 |
| 2017 | 1.15 |
| 2016 | 1.12 |
| 2015 | 1.11 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
